Evaxion Biotech's total assets for Q4 2025 were $28.41M, a decrease of -4.47% from the previous quarter. EVAX total liabilities were $11.37M for the fiscal quarter, a -13.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.